Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. YB
YB logo

YB Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Yuanbao Inc (YB) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Sell
Latest Price
12.700
1 Day change
-9.74%
52 Week Range
31.000
Analysis Updated At
2026/05/22
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Yuanbao Inc (YB) is not a good buy right now for a beginner with a long-term focus and $50,000-$100,000 to invest. The stock is in a clear short-term downtrend, the proprietary signals are absent, analyst coverage is only neutral, and there is no fresh news or financial data to support an immediate long-term entry. Given the user's impatient profile and preference for a direct decision, the better call is to avoid buying now.

Technical Analysis

Technically, YB looks weak. The stock is down 7.68% in regular trading and another 6.89% pre-market, showing heavy selling pressure. MACD histogram is negative and worsening, which confirms bearish momentum. RSI_6 at 13.652 is extremely oversold, but oversold alone does not make it a buy when trend structure is still bearish. Moving averages are stacked bearishly with SMA_200 > SMA_20 > SMA_5, signaling the price is below both medium- and long-term trend support. Price is also sitting near S1 at 13.087, just above S2 at 12.318, which means the stock is near support but not yet showing reversal strength. Overall trend: bearish.

Positive Catalysts

  • ["RSI is deeply oversold, which can sometimes lead to a short-term rebound.", "The stock is trading near a support zone around 13.087.", "Citi initiated coverage with a Neutral rating and a $21.80 price target, which is above the current price."]

Neutral/Negative Catalysts

  • ["Sharp current price decline of 7.68% in regular trading and 6.89% pre-market.", "MACD histogram is below zero and worsening, confirming bearish momentum.", "Bearish moving-average alignment: SMA_200 > SMA_20 > SMA_5.", "No news in the recent week to support a catalyst-driven rebound.", "Hedge funds and insiders are both neutral, with no meaningful accumulation signal.", "No signal from AI Stock Picker or SwingMax."]

Financial Performance

No latest quarter financial data was available because the financial snapshot returned an error, so there is no usable quarter-by-quarter revenue or earnings trend to assess. As a result, there is no confirmed recent financial acceleration or deterioration to support a buy decision.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent analyst activity is limited to Citi initiating coverage on 2026-02-23 with a Neutral rating and a $21.80 price target. Citi said Yuanbao is fairly valued at current levels. This means Wall Street's view is mixed-to-neutral rather than bullish: the pro side is that the target is well above the current price, but the con side is that the rating is not an outright Buy and implies limited immediate upside conviction.

Wall Street analysts forecast YB stock price to rise
Analyst Rating
0
Wall Street analysts forecast YB stock price to rise
Buy
Hold
Sell
0
Current: 14.070
sliders
Low
0
Averages
0
High
0
0
Current: 14.070
sliders
Low
0
Averages
0
High
0
Citi
Neutral
initiated
$21.80
AI Analysis
2026-02-23
Reason
Citi
Price Target
$21.80
AI Analysis
2026-02-23
initiated
Neutral
Reason
Citi initiated coverage of Yuanbao with a Neutral rating and $21.80 price target. The company is a leading online insurance broker in China focusing on health insurance, the analyst tells investors in a research note. Citi believes the shares are fairly valued at current levels.

People Also Watch